Keishi Sugimachi

15PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer diagnosisCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 03, 2026
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.

|Mar 09, 2026
Combination of Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment.

Tomonari Shimagaki, Keishi Sugimachi, Takahiro Tomino

|Dec 30, 2025
Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with Gemcitabine + Cisplatin + Durvalumab.

Yusuke Morita, Rie Sugimoto, Miho Kurokawa

|Jun 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.

Kosuke Hirose, Takaaki Masuda, Hajime Otsu

|May 26, 2025
The EZ-ALBI score as a prognostic tool for outcomes after resection of small hepatocellular carcinoma (≤3 cm).

Tomonari Shimagaki, Keishi Sugimachi, Takahiro Tomino

|May 19, 2025
Combined effect of frailty and sarcopenia on postoperative complications in older adults undergoing curative surgery for hepato-biliary-pancreatic cancer.

Norifumi Harimoto, Keishi Sugimachi, Tomohiro F Nishijima

Pageof 3

Frequent Collaborators

4 joint publications

Tomonari Shimagaki

3 joint publications

Takaaki Masuda

3 joint publications

Koshi Mimori

2 joint publications

Masahiko Sugiyama